ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,870.62
-1.32%
US Tech 100
19,880.00
-2.30%
다우존스 지수
43,444.99
-0.70%
Bitcoin
90,556.95
-0.55%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) 시세

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
11.19
-0.67
(-5.65%)
마감 17 11월 6:00AM
15분 지연
11.19
-0.01
(-0.09%)
시간외 거래: 8:55AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
11.19
매수가
10.00
매도가
11.82
거래량
546,105
11.16 일간 변동폭 11.95
10.6001 52주 범위 20.70
market_cap
472.211M
전일 종가
11.86
개장가
11.95
최근 거래 시간
42
@
11.21
마지막 거래 시간
재정 규모
US$ 6,283,634
VWAP
11.5063
평균 볼륨(3m)
587,537
발행 주식
42,199,414
배당수익률
-
주가수익률
-4.62
주당순이익(EPS)
-2.42
매출
82.71M
순이익
-102.24M

UroGen Pharma Ltd 정보

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.urogen.com
본부
Ra'anana, Center, Isr
설립됨
-
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker URGN. The last closing price for UroGen Pharma was US$11.86. Over the last year, UroGen Pharma shares have traded in a share price range of US$ 10.6001 to US$ 20.70.

UroGen Pharma currently has 42,199,414 shares in issue. The market capitalisation of UroGen Pharma is US$500.49 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.62.

URGN 최신 뉴스

추가 뉴스

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

06 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

06 11월 2024
Edgar (US Regulatory)

UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

New Drug Application for UGN-102 accepted by US FDA; PDUFA target action date set for June 13, 2025 JELMYTO® achieved net product sales of $25.2 million in Q3 2024, compared to $20.9 million in...

06 11월 2024
Business Wire

UroGen Pharma to Present at the Guggenheim Securities Healthcare Innovation Conference

Fireside Chat on November 12, 2024 at 3:00 PM ET UroGen Pharma Ltd. (Nasdaq:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and...

05 11월 2024
Business Wire

UroGen Pharma to Report Third Quarter Financial Results on Wednesday, November 6, 2024

Conference Call and Webcast Scheduled for Wednesday, November 6, 2024, at 10:00AM ET UroGen Pharma Ltd. (Nasdaq:URGN), a biotech company dedicated to developing and commercializing innovative...

30 10월 2024
Business Wire

ENVISION Trial Results Published in the Journal of Urology Report 82.3% Duration of Response 12 Months after Achieving Complete Response for UGN-102, Potentially First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC

The Kaplan-Meier Estimate of Duration of Response at 12 Months in Patients Who Achieved a Complete Response at Three Months was 82.3% Patients Receiving UGN-102 had a 79.6% Complete Response...

28 10월 2024
Business Wire

UroGen Announces FDA Acceptance of its New Drug Application for UGN-102

PDUFA goal date set for June 13, 2025 UGN-102 would be the first FDA-approved medicine for LG-IR-NMIBC, if approved UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing...

16 10월 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

10 10월 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

10 10월 2024
Edgar (US Regulatory)

Form 8-K - Current report

09 10월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.94-7.7493816982712.1312.8111.1937481712.28794481CS
4-1.69-13.121118012412.8813.3311.1945241412.34749356CS
12-3.3-22.774327122214.4915.0211.1958753712.80159267CS
26-1.94-14.775323686213.1320.711.1962228414.70654692CS
52-0.36-3.1168831168811.5520.710.600147450114.90520956CS
156-7.22-39.217816404118.4124.134.8529542414.09434508CS
260-15.07-57.387661843126.2635.214.8524258516.29741188CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CEROCERo Therapeutics Holdings Inc
US$ 0.2853
(52.40%)
1.17B
CYCNCyclerion Therapeutics Inc
US$ 2.5306
(42.97%)
11.99M
SPPLSIMPPLE Ltd
US$ 1.2503
(41.60%)
165.69M
PULMPulmatrix Inc
US$ 6.5586
(39.54%)
5.37M
ZTEKZentek Ltd
US$ 1.2574
(29.96%)
309.67k
TFFPTFF Pharmaceuticals Inc
US$ 0.376101
(-76.49%)
9.35M
EYENEyenovia Inc
US$ 0.10185
(-70.05%)
52.8M
CTXRCitius Pharmaceuticals Inc
US$ 0.1974
(-39.89%)
11.26M
VVPRVivoPower International PLC
US$ 0.8151
(-39.62%)
2.34M
IPWiPower Inc
US$ 0.7302
(-39.15%)
1.15M
CEROCERo Therapeutics Holdings Inc
US$ 0.2853
(52.40%)
1.17B
ELABElevai Labs Inc
US$ 0.0211
(-19.47%)
380.03M
NVDANVIDIA Corporation
US$ 141.98
(-3.26%)
253.02M
SPPLSIMPPLE Ltd
US$ 1.2503
(41.60%)
165.69M
STISolidion Technology Inc
US$ 0.44
(25.71%)
140.02M

토론

전체 피드 보기
marcis marcis 2 분 전
I would check all those mergers
They may have domicile in Canada.

Many big brand names like BMW Apple have pulled out
China has money problems and what went for years “off the book” paying of people tax inspectors, it has recently changed with now many foreign and dome
IGPK
pochemunyet pochemunyet 2 분 전
Oh, I thought it was only Mike who was buffering, freezing and lagging...
LWLG
Farmboynate Farmboynate 3 분 전
Simple OTCM dilution MM's know when its coming Can short the stock push it lower then cover when those shares hit
OTCM
BrownRickRoss BrownRickRoss 3 분 전
Because I NEVER underestimate a poster’s intentions. You being here reminding us that it’s revoked and trolling us nonstop tells me all I need to know. Giants still suck my guy!
Jack_Bolander Jack_Bolander 4 분 전
d-1 - We need lots of energy ... all forms, but let's be intelligent about it. `

Let's use the best fuels for their best applications and stop wasting valuable time , money and resources trying to make an expensive fuel work in an ineffective application.

Hydrogen isn
NeoSunTzu NeoSunTzu 4 분 전
All Fnnie and Freddie related comments, suggestions, posts, etc. about the FHFA to the incoming admin or others assisting us should strongly emphasize the negligent, bordering or criminal handling of the conservatorship, including the self-dealing with Treasury. Maybe this attached phrase would help
FNMA
silverlion silverlion 5 분 전
Real assets.
SDRC
CorsairNavigator20 CorsairNavigator20 5 분 전
BK
Sorry to be off topic, read somewhere that 4 of the analysists have lowered their ratings. Have you seen or heard if that's true. I can't find any more details and wondering if it is a short piece. Also any ideas on the end of day trade, shows up here but not on Yahoo.
IOVA
kbaz kbaz 5 분 전
Betting there's a chance that $FRZT in a Movement to Revolutionize the MEME TOKEN and NFT Commerce Community. MUNZEE shut down the Need for Capital. No Reverse Split nor Dilution necessity has created a big time inconsistency of Price Action vs Progression of Company Application Developmen
FRZT
chemist72 chemist72 5 분 전
I'm very bearish on MVNT share price in the near term. Two reasons.

1) I believe they are at risk of receiving a "shell risk" flag from OTCM. (see my previous post)
2) Even if they do get a few orders for some small valves, I don't expect them to be able to show much more reven
MVNT OTCM
fink fink 7 분 전
Pure Widon in that post.
ZHUD
Eli-316 Eli-316 8 분 전
When he said he sold at 7, that was the high since early in the year.  We hadn't even hit 8s or 9s...

When you tell the truth, you don't have to remember a lie. 


CGAC
georgebailey georgebailey 8 분 전
I’d like an attorney to opine on your opinion Steady T.
I have a different opinion. I think LP can execute a contract that is not effective until a contingency is triggered like MHRA approval.
Without the contingency occurring there is no contact much less a material event.
NWBO
StarlingChaser StarlingChaser 8 분 전
At least we now have a chip and a chair, still in it.
BYOC
KISSINGER KISSINGER 8 분 전
Find another board PNV. Nobody cares about your opinions especially that you own ZERO stock.

CG = Genius!!

GET IT YET???
AHRO
Nebuchadnezzar Nebuchadnezzar 9 분 전
needs to break 0003s then 0004s

MM wall at 0003 bc they dont want it to run yet
BOTY
fink fink 9 분 전
Why Monday?
Do you need to sell and pay the rent?

We need to see that NAzdaq application filed to uplist. Screw some blip of an update Monday.
Some things are out of Cohens hands. Wait for the symbol/name change. That wait and stall will break the most hard core longs
ZHUD
Nebuchadnezzar Nebuchadnezzar 10 분 전
BOTY!! MM wall at 0003 once broken it has a chance to breathe and move to 0004-0008

WAKE UP THE OTC with BIG OL BOTY and RITE

RITE looks ready for much bigger move

the OTC NEEDS TO WAKE THE FK UP
BOTY
iateclube iateclube 10 분 전
Bob,, agree on that 85% failure rate, the RS usually just creates a new downhill slide for shorts to plunder. Wash, rinse, repeat. I have known of succedssful RS's
where the underlying business is solid and the future is bright, especially if they are applying for a listing. One of my favo
LQMT
train21 train21 11 분 전
$PSRU LETS GO GO GO GO GO GO
BUY SOME CHEAP SHARE NOW IF YOU CAN >>>>???
PSRU
getmoreshares getmoreshares 11 분 전
NEVER forget the TAX MAN!
CGAC
train21 train21 12 분 전
$PSRU AT SOME POINT THIS WILL START TO RUN THEN
all will chase it up ?????? $$$$$$$$$$$$$
PSRU

최근 히스토리

NASDAQ
URGN
UroGen Pharma
TG
SUMA
Sumitomo
BIT
Q00667
Leonteq Securities
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유